Interventional stroke therapy: The potential benefit of direct intra-arterial infusion

Reviews in Cardiovascular Medicine

Volumn 3, Issue SUPPL. 2, 2002, Pages

  Connors III, John J ^a  

^a ST JOSEPH HOSPITAL   (United States)

Author keywords

Acute ischemic stroke; Arteriogram; Flow enhancement; INSTOR; Intra arterial thrombolysis; Neuro guide catheter; Revascularization

Indexed keywords

ALTEPLASE; ANISTREPLASE; FIBRIN; FIBRINOLYTIC AGENT; HEPARIN; PROUROKINASE; RETEPLASE; SARUPLASE; STREPTOKINASE; TENECTEPLASE; UROKINASE;

BLEEDING; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG SELECTIVITY; FOOD AND DRUG ADMINISTRATION; HUMAN; REGISTER; REVASCULARIZATION; REVIEW; STROKE; TREATMENT OUTCOME; UNITED STATES; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FIBRINOLYTIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PATIENT SELECTION; PHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; INTRACRANIAL ARTERIOSCLEROSIS; PATIENT SELECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; THROMBOLYTIC THERAPY;

EID: 0036991701     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev. 1994;6:257-286.
2. Heiss WD, Graf R, Weinhard J, et al. Dynamic penumbra demonstrated by sequential multi-tracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab. 1994;14;892-902.
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
5. Nighoghossian N, Trouillas P, Adeleine P, Salord F. Hyperbaric oxygen in the treatment of acute ischemic stroke: a double-blind pilot study. Stroke. 1995;26:1369-1372.
6. Schwab S, Schwarz S, Keller E, et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery (MCA) territory infarction: a pilot study. Presented at the Twenty-Third International Joint Conference on Stroke and Cerebral Circulation; February 1998; Orlando, FL.
7. Donnan GA, Davis SM, Chambers BR, et al. Australian streptokinase trial (ASK). In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. Berlin: Springer-Verlag; 1993;80-85.
8. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischemic stroke. Lancet. 1995;345:579. Letter.
9. Donnan GA, Hommel M, Davis SM, for the Steering Committees of the ASK and MAST-E Trials. Streptokinase in acute ischemic stroke. Lancet. 1995;346:56. (Letter.)
10. The Multicenter Acute Stroke Trial-Europe. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-150.
11. Hacke W, Kasto M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
12. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
13. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolyfic therapy. AJNR Am J Neuroradiol. 1996;17:79-85.
14. NINDS t-PA Stroke Study Group. Generalized efficacy of rt-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-2125.
15. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
16. Brott T, Haley E Jr., Levy D, et al. Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:632-640.
17. Wolpert S, Bruckmann H, Greenlee R, et al, and the rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 1993;14:3-13.
18. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol. 1994;15:1817-1822.
19. Zeumer H, Freitag H-J, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology. 1993;35:159-162.
20. Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolyfic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke. 1996;27:875-881.
21. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216-1222.
22. Higashida RT, Halbach VV, Barnwell SL, et al. Thrombolytic therapy in acute stroke. J Endovasc Surg. 1994;1:4-15.
23. Theron J, Coskun O, Huet H, et al. Local intraarterial thrombolysis in the carotid territory. Interventional Neuroradiol. 1996;2:111-126.
24. Theron J., Courtheoux P, Casasco A, et al. Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol. 1989;10:753-765.
25. Higashida RT, Hieshima G, Halbach VV. Intravascular techniques for angioplasty and thrombolysis. In: Weinstein P and Fadden A, eds. Current Neurosurgical Practice. Protection of the Brain from Ischemia. Baltimore, MD: Williams and Wilkins; 1989;279-284.
26. Zeumer H, Freitag H, Knowpe V. Intravascular thrombolysis in central nervous system cerebrovascular disease. Neuroimaging Clin N Am. 1992;2:359-369.
27. Higashida R, Helmer E, Halbach V, Hieshima G. Direct thrombolytic therapy for superior sagittal sinus thrombosis. AJNR Am J Neuroradiol. 1989;10:S4-S6.
28. Barnwell S, Higashida R, Halbach V, et al. Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery. 1991;28:135-142.
29. Higashida RT, Hieshima G, Halbach VV. Advances in the treatment of complex cerebrovascular disorders by interventional neurovascular techniques. Circulation. 1991;83:196-206.
30. Tsai F, Higashida R, Matovich V, Alfieri K. Acute thrombosis of the intracranial dural sinus: direct thrombolyfic treatment. AJNR Am J Neuroradiol. 1992;13:1137-1141.
31. Fletcher A, Alkjaersig N, Lewis M, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976;7:135-142.
32. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-812.
33. Zeumer H. Vascular recanalizing techniques in interventional neuroradiology. J Neurol. 1985;231:287-294.
34. Francis R. Fibrinolysis and stroke: implications for pathogenesis and therapy. In: Fisher M, ed. Medical Therapy of Acute Stroke. New York: Marcel Dekker; 1989; 97-108.
35. Zivin J, Fisher M, DeGirolami U, et al. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985;230:1289-1292.
36. Marder V. The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med. 1979;90:802-808.
37. Gurewich V, Pannell R, Louie S, et al. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest. 1984;17:331-339.
38. Marshall J. Clinical aspects of stroke. In: Fisher M, ed. Medical Therapy of Acute Stroke. New York: Marcel Decker; 1989; 1-11.
39. del Zoppo G, Zeumer H, Harker L. Thrombolytic therapy in stroke: possibilities and hazards. Stroke. 1986;17:595-607.
40. Verstraete M. Biochemical and clinical aspects of thrombolysis. Semin Hematol. 1978;15:35-54.
41. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
42. Chimowitz MI, Kokkinos J, Strong J, et al: The warfarin-aspirin symptomatic intracranial disease study. Neurol. 1995;45:1488-1493.
43. Barth A, Bogousslavsky J, Regli F. The clinical and topographic spectrum of cerebellar infarcts: a clinical-magnetic imaging correlation study. Ann Neurol. 1993;33:451-456.
44. Furlan AJ. Natural history of atherothrombotic occlusion of cerebral arteries: carotid versus vertebrobasilar territories. In: Hacke W, ed. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg: Springer-Verlag; 1991.
45. Hornig CR, Buttner T, Hoffman O, Dorndoff W. Short-term prognosis of vertebrobasilar ischemic stroke. Cardiovasc Dis. 1992;2:273-281.
46. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.